9 Matching Annotations
  1. Last 7 days
  2. aacrjournals.org aacrjournals.org
    Serglycin Drives LAG3+ Treg Differentiation and Immunosuppression in Gastric Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerres/article/86/10/2395/784887/Serglycin-Drives-LAG3-Treg-Differentiation-and
  3. May 2026
  4. 54.241.53.176 54.241.53.176
    2026.05.18.725972.full-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    54.241.53.176/62122d599e4fb8fdbae3d55b0c5597916ef620c8/2026.05.18.725972.full-html.html
  5. Apr 2026
  6. aacrjournals.org aacrjournals.org
    Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerdiscovery/article/15/10/2054/765955/Extrachromosomal-DNA-Driven-Oncogene-Dosage
  7. www.science.org www.science.org
    Claudins interact with LILRB immune inhibitory receptors to promote myeloid immunosuppression in cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    science.org/doi/10.1126/sciimmunol.adt7832
  8. Dec 2025
  9. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Eph receptors activate myeloid checkpoint receptor LILRB5 to support tumor development
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12137008/
  10. Jun 2025
  11. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Phosphatase activity is dispensable for PRL-3-mediated oncogenesis and tumor progression
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12132575/
  12. Apr 2025
  13. 52.53.155.43 52.53.155.43
    PDF-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/6082e85085e2ed08cbf86aa32472ba192b5c95f0/PDF-html.html
  14. Jan 2023
  15. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9799175/
  16. Sep 2021
  17. www.sciencedirect.com www.sciencedirect.com
    Live Imaging of SARS-CoV-2 Infection in Mice Reveals that Neutralizing Antibodies Require Fc Function for Optimal Efficacy
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1074761321003472